Showing results (201-210 of 227) with videos related to

Sort By:
Pageof 23
JAMA|August 27, 2009
Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapyAlan R Shuldiner, Jeffrey R O'Connell, Kevin P Bliden, et al.
Thrombosis and Haemostasis|January 12, 2023
Post-PCI Risk Assessment by Inflammation Activity According to Disease Acuity and Time from ProcedureHaegeun Song, Jong-Hwa Ahn, Min Gyu Kang, et al.
Pharmacogenetics and Genomics|November 1, 2012
The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel responseJoshua P Lewis, Richard B Horenstein, Kathleen Ryan, et al.
Journal of the American College of Cardiology|April 23, 2013
The influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel: the PARADOX studyPaul A Gurbel, Kevin P Bliden, Douglas K Logan, et al.
Thrombosis and Haemostasis|January 5, 2019
Influence of Amlodipine on Haemostatic Measurements during Clopidogrel Treatment in Patients with Coronary Artery DiseaseJin-Sin Koh, Yongwhi Park, Jong-Hwa Ahn, et al.
Science Bulletin|January 20, 2023
2018 update of expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCIYong Huo, Young-Hoon Jeong, Yanjun Gong, et al.
JACC. Asia|November 7, 2022
Residual Inflammatory Risk and its Association With Events in East Asian Patients After Coronary InterventionJong-Hwa Ahn, Udaya S Tantry, Min Gyu Kang, et al.
Pageof 23